Nomad Foods Limited (NYSE:NOMD ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 3:45 PM EDT Company Participants Stéfan Descheemaeker - CEO & Director Ruben Baldew - CFO & Director Conference Call Participants Andrew Lazar - Barclays Bank PLC, Research Division Presentation Andrew Lazar MD & Senior Research Analyst All right. Good afternoon, everybody.
Nomad Foods (NOMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Nomad Foods Limited's Q2 '25 results were weak, with revenue and margins pressured by hot European weather and cost inflation. Gross margin decline was significant, driven by cost inflation and limited pricing power due to retailer renegotiation schedules. Valuation now offers a 9% earnings yield, but organic growth is modest, and the stock is only fairly valued, not cheap.
Nomad Foods Limited (NYSE:NOMD ) Q2 2025 Earnings Call August 6, 2025 8:30 AM ET Company Participants Jason English - Corporate Participant Ruben Sewnarain Baldew - CFO & Director Stefan Descheemaeker - CEO & Director Conference Call Participants Andrew Lazar - Barclays Bank PLC, Research Division John Joseph Baumgartner - Mizuho Securities USA LLC, Research Division Jonathan E. Tanwanteng - CJS Securities, Inc. Scott Michael Marks - Jefferies LLC, Research Division Stephen Robert R.
Nomad Foods (NOMD) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.47 per share a year ago.
Nomad Foods (NOMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The mean of analysts' price targets for Nomad Foods (NOMD) points to a 37.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NOMD bets on fish innovation and brand revamps to counter falling revenue, volume and organic sales trends.
NOMD takes gradual pricing steps to counter protein cost inflation, as margin pressure begins to emerge.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NOMD's low valuation, rising innovation and strong European category gains hint at a timely value opportunity.